Korys, the Colruyt family's investment structure, builds diversified portfolios for long-term, sustainable impact in Cleantech, retail, and life sciences.
Location
Halle, Flemish Brabant, BE
Founded
2012
Korys, the investment arm of the Colruyt family, focuses on building diversified portfolios with a long-term, sustainable impact in sectors such as Cleantech, retail, and life sciences. They typically engage in Series C and other unspecified investment rounds, supporting small and medium-sized companies through direct participations and private equity funds.
Notable portfolio companies include Amphivena Therapeutics and Bricsnet. Korys leverages the entrepreneurial spirit of the Colruyt family, aiming to create a positive impact on people and the planet. Their investment philosophy emphasizes collaboration with other companies to shape a sustainable future, offering expertise and dedication to drive long-term growth.
Korys - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies4
Current Portfolio Count3
Top Investment Stages
Series B2 (50.0%)
Series C2 (50.0%)
Stage Mix
Series B 50%Series C 50%
Concentration shown as share of disclosed investments by stage.
